부산대학교 도서관

Alvarado D; Celldex Therapeutics, Hampton, New Jersey, USA.; Maurer DM; Celldex Therapeutics, Hampton, New Jersey, USA.; Golden P; Celldex Therapeutics, Hampton, New Jersey, USA.; Hawthorne T; Celldex Therapeutics, Hampton, New Jersey, USA.; Thomas LJ; Celldex Therapeutics, Hampton, New Jersey, USA.; Heath-Chiozzi M; Celldex Therapeutics, Hampton, New Jersey, USA.; Keler T; Celldex Therapeutics, Hampton, New Jersey, USA.; Crowley E; Celldex Therapeutics, Hampton, New Jersey, USA.; Young D; Celldex Therapeutics, Hampton, New Jersey, USA.; Terhorst-Molawi D; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.; Munoz M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.; Metz M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.

Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE; In Process

Khalil DN; Memorial Sloan Kettering Cancer Center New York, NY United States.; Gomez R; Weill Cornell Medicine New York, NY United States.; Regev A; Weill Cornell Medicine New York, NY United States.; Samaan F; Weill Cornell Medicine New York, NY United States.; Marouf Y; Weill Cornell Medicine New York, NY United States.; Budhu S; Weill Cornell Medicine New York, New York United States.; Hirschhorn D; Weill Cornell Medicine New York, NY United States.; Schulze I; Memorial Sloan Kettering Cancer Center New York, NY United States.; Lavery JA; Memorial Sloan Kettering Cancer Center New York, New York United States.; Ceglia N; Memorial Sloan Kettering Cancer Center United States.; Freeman SS; Memorial Sloan Kettering Cancer Center New York, New York United States.; Maltez VI; National Institute of Allergy and Infectious Diseases Bethesda, MD United States.; Garcia JM; National Institute of Allergy and Infectious Diseases Bethesda, MD United States.; Suek N; Weill Cornell Medicine New York, NY United States.; Weng CH; Weill Cornell Medicine New York, NY United States.; Cabanski CR; Parker Institute for Cancer Immunotherapy San Francisco, CA United States.; Monette S; Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine New York, New York United States.; Romin Y; Memorial Sloan Kettering Cancer Center New York, NY United States.; Li Y; Bristol-Myers Squibb (United States) Cambridge, MA United States.; Chaligne R; Memorial Sloan Kettering Cancer Center New York, NY United States.; Yellin MJ; Celldex Therapeutics (United States) Hampton, New Jersey United States.; Keler T; Celldex Therapeutics, Inc. Hampton, NJ United States.; Maurer DM; Celldex Therapeutics (United States) Hampton, NJ United States.; Flamar AL; Weill Cornell Medicine New York, NY United States.; Morgado-Palacin L; Weill Cornell Medicine New York, NY United States.; Mangarin LM; Weill Cornell Medicine.; Harding JJ; Memorial Sloan Kettering Cancer Center New York, NY United States.; Park W; Memorial Sloan Kettering Cancer Center New York, NY United States.; Lyman JP; Lustgarten Foundation Uniondale, NY United States.; Maddock S; Parker Institute for Cancer Immunotherapy San Francisco, CA United States.; O'Hara MH; University of Pennsylvania Philadelphia, PA United States.; Abou-Alfa GK; Memorial Sloan Kettering Cancer Center New York, NY United States.; Vonderheide RH; University of Pennsylvania Philadelphia, Pennsylvania United States.; O'Reilly EM; Memorial Sloan Kettering Cancer Center New York, NY United States.; Germain RN; National Institute of Allergy and Infectious Diseases Bethesda, MD United States.; Wolchok JD; Weill Cornell Medicine New York, NY United States.; Merghoub T; Weill Cornell Medicine New York, NY United States.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Murphy MB; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Vitale L; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; O'Neill T; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Maurer DM; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Malenchek L; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Crocker A; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Patterson C; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Mills-Chen L; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Saley V; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Antczak NM; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Boyer JM; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; McManus KM; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Montanari NR; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Hammond RA; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Goldstein J; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Thomas LJ; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Keler T; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.; Alvarado D; Celldex Therapeutics, Inc., Hampton, New Jersey, USA.

Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE

Adamik J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; Munson PV; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; Hartmann FJ; Systems Immunology and Single-Cell Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bendall SC; Department of Pathology, Stanford University, Palo Alto, CA, 94304, USA.; Argüello RJ; Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.; Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA. lisa.butterfield@ucsf.edu.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. lisa.butterfield@ucsf.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Maurer, Deena M; Butterfield, Lisa H; Vujanovic, Lazar

Melanoma Research, vol 29, iss 2

Till JE; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; McDaniel L; Personalis, Inc., Menlo Park, CA, USA.; Chang C; Indiana University School of Medicine, Indianapolis, IN, USA.; Long Q; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Pfeiffer SM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Padrón LJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Yu JX; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Da Silva DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Abbott C; Personalis, Inc., Menlo Park, CA, USA.; Chen RO; Personalis, Inc., Menlo Park, CA, USA.; Boyle SM; Personalis, Inc., Menlo Park, CA, USA.; Bhagwat N; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Cannas S; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Sagreiya H; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Li W; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Yee SS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Abdalla A; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Wang Z; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Yin M; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Ballinger D; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Wissel P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Eads J; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Karasic T; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Schneider C; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; O'Dwyer P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Teitelbaum U; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Reiss KA; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Rahma OE; Dana-Farber Cancer Institute, Boston, MA, USA.; Fisher GA; Stanford University, Stanford, CA, USA.; Ko AH; University of California, San Francisco, San Francisco, CA, USA.; Wainberg ZA; University of California, Los Angeles, Los Angeles, CA, USA.; Wolff RA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; O'Hara MH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Vonderheide RH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Carpenter EL; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. erical@upenn.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Bucktrout SL; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA. sbucktrout@parkerici.org.; Banovich NE; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.; Butterfield LH; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Cimen-Bozkus C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Giles JR; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Good Z; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stanford Cancer Institute and Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Goodman D; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Microbiology and Immunology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.; Jonsson VD; Department of Applied Mathematics, University of California, Santa Cruz, Santa Cruz, CA, USA.; Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.; Genomics Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.; Lareau C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Marson A; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Gladstone-UCSF Institute for Genomic Immunology, San Francisco, CA, USA.; Maurer DM; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Munson PV; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stubbington M; 10x Genomics, Pleasanton, CA, USA.; Taylor S; 10x Genomics, Pleasanton, CA, USA.; Cutchin A; 10x Genomics, Pleasanton, CA, USA.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE

Bucktrout SL; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA. sbucktrout@parkerici.org.; Banovich NE; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.; Butterfield LH; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Cimen-Bozkus C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Giles JR; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Good Z; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stanford Cancer Institute and Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Goodman D; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Microbiology and Immunology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.; Jonsson VD; Department of Applied Mathematics, University of California, Santa Cruz, Santa Cruz, CA, USA.; Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.; Genomics Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.; Lareau C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Marson A; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Gladstone-UCSF Institute for Genomic Immunology, San Francisco, CA, USA.; Maurer DM; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Munson PV; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stubbington M; 10x Genomics, Pleasanton, CA, USA.; Taylor S; 10x Genomics, Pleasanton, CA, USA.; Cutchin A; 10x Genomics, Pleasanton, CA, USA.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Padrón LJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. lpadron@parkerici.org.; Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; O'Hara MH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Wolff RA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wainberg ZA; University of California, Los Angeles, Los Angeles, CA, USA.; Ko AH; University of California, San Francisco, San Francisco, CA, USA.; Fisher G; Stanford University, Stanford, CA, USA.; Rahma O; Dana-Farber Cancer Institute, Boston, MA, USA.; Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Yu JX; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Pfeiffer SM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Spasic M; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Xu J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Karakunnel J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Mick R; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Alanio C; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Byrne KT; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.; Hollmann TJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Moore JS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Jones DD; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Tognetti M; Biognosys AG, Schlieren, Switzerland.; Chen RO; Personalis, Inc., Menlo Park, CA, USA.; Yang X; Apexigen, Inc., San Carlos, CA, USA.; Salvador L; Bristol Myers Squibb, New York, NY, USA.; Wherry EJ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Dugan U; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; O'Donnell-Tormey J; Cancer Research Institute, New York, NY, USA.; Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Hubbard-Lucey VM; Cancer Research Institute, New York, NY, USA.; Ibrahim R; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Bucktrout S; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Vonderheide RH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. rhv@upenn.edu.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA. rhv@upenn.edu.; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. rhv@upenn.edu.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Maurer DM; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Adamik J; Parker Institute for Cancer Immunotherapy, and University of California San Francisco, Microbiology and Immunology, San Francisco, California.; Santos PM; UPMC Hillman Cancer Center, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; Shi J; UPMC Hillman Cancer Center, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; Shurin MR; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Kirkwood JM; UPMC Hillman Cancer Center, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; Storkus WJ; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania.; Butterfield LH; Parker Institute for Cancer Immunotherapy, and University of California San Francisco, Microbiology and Immunology, San Francisco, California. lbutterfield@parkerici.org.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Butterfield LH; Department of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA. lbutterfield@parkerici.org.; Department of Surgery, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA. lbutterfield@parkerici.org.; Department of Immunology, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA. lbutterfield@parkerici.org.; UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA. lbutterfield@parkerici.org.; Vujanovic L; Department of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; Santos PM; Department of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; Maurer DM; Department of Immunology, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; Gambotto A; Department of Surgery, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; Lohr J; Department of Immunology, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; Li C; UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; Present address: Tsinghua University School of Medicine, Beijing, China.; Waldman J; Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.; Chandran U; Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.; Lin Y; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.; Lin H; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.; Tawbi HA; Department of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; Present address: Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tarhini AA; Department of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; Present address: Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.; Kirkwood JM; Department of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.; UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA, 15213, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Paz H; Department of Surgery, University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, CA, 90095, USA.; Tsoi J; Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California, Los Angeles, CA, 90095, USA.; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.; Kalbasi A; Department of Surgery, University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, CA, 90095, USA.; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, 90095, USA.; Grasso CS; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.; McBride WH; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.; Schaue D; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.; Butterfield LH; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, 15213, USA.; Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA, 15213, USA.; Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, PA, 15213, USA.; Department of Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, 15213, USA.; Maurer DM; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, 15213, USA.; Ribas A; Department of Surgery, University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, CA, 90095, USA.; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, 90095, USA.; Graeber TG; Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California, Los Angeles, CA, 90095, USA.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, 90095, USA.; Economou JS; Department of Surgery, University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, CA, 90095, USA. jeconomou@mednet.ucla.edu.; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, 90095, USA. jeconomou@mednet.ucla.edu.; Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California, Los Angeles, CA, 90095, USA. jeconomou@mednet.ucla.edu.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, 90095, USA. jeconomou@mednet.ucla.edu.

Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE